T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
IonQ
IONQ
$18.2B
| $28.8M | ﹤0.01% |
688,764
+569,061
| +475% | +$14.3M |
|
902
Rollins
ROL
$17.4B
| $28.7M | ﹤0.01% |
618,978
+961
| +0.2% | +$47.1K |
|
903
Addus HomeCare
ADUS
$2.2B
| $28.4M | ﹤0.01% |
226,636
+1,087
| +0.5% | +$137K |
|
904
iShares Core MSCI EAFE ETF
IEFA
$196B
| $28.3M | ﹤0.01% |
402,979
+69,980
| +21% | +$5.16M |
|
905
Griffon
GFF
$4.8B
| $28.2M | ﹤0.01% |
395,926
-1,981
| -0.5% | -$144K |
|
906
Akamai
AKAM
$17.6B
| $28.2M | ﹤0.01% |
294,809
-34,312
| -10% | -$3.37M |
|
907
Advanced Energy
AEIS
$13.5B
| $28M | ﹤0.01% |
242,057
-85,210
| -26% | -$9.58M |
|
908
Rush Street Interactive
RSI
$2.85B
| $27.8M | ﹤0.01% |
2,029,239
+2,004,059
| +7,959% | +$24.4M |
|
909
Itaú Unibanco
ITUB
$80.9B
| $27.8M | ﹤0.01% |
6,352,168
-15,795,768
| -71% | -$81.3M |
|
910
Haemonetics
HAE
$4.11B
| $27.7M | ﹤0.01% |
354,281
+25,617
| +8% | +$2.06M |
|
911
First Advantage
FA
$3.81B
| $27.5M | ﹤0.01% |
1,469,272
+769,825
| +110% | +$14.6M |
|
912
iShares Core S&P 500 ETF
IVV
$910B
| $27.4M | ﹤0.01% |
46,539
+4,134
| +10% | +$2.45M |
|
913
Citizens Financial Group
CFG
$31.2B
| $27.3M | ﹤0.01% |
624,794
-18,162
| -3% | -$803K |
|
914
Essential Properties Realty Trust
EPRT
$6.71B
| $27.3M | ﹤0.01% |
873,983
+50,012
| +6% | +$1.64M |
|
915
LyondellBasell Industries
LYB
$20.2B
| $27.2M | ﹤0.01% |
366,472
+6,945
| +2% | +$584K |
|
916
BridgeBio Pharma
BBIO
$16.4B
| $27.2M | ﹤0.01% |
991,238
+180,773
| +22% | +$4.67M |
|
917
CG Oncology
CGON
$6.62B
| $27.1M | ﹤0.01% |
945,194
+353,787
| +60% | +$12.1M |
|
918
Labcorp
LH
$26.2B
| $27M | ﹤0.01% |
117,837
-328
| -0.3% | -$75.2K |
|
919
Leonardo DRS
DRS
$11.9B
| $27M | ﹤0.01% |
836,293
-1,122,829
| -57% | -$36.5M |
|
920
A10 Networks
ATEN
$2B
| $27M | ﹤0.01% |
1,467,993
+37,733
| +3% | +$616K |
|
|
BCAX
921
Bicara Therapeutics
BCAX
$1.63B
| $27M | ﹤0.01% |
1,547,180
+8,246
| +0.5% | +$172K |
|
922
Factset
FDS
$10.2B
| $26.6M | ﹤0.01% |
55,296
-91,729
| -62% | -$43.6M |
|
923
LeMaitre Vascular
LMAT
$1.87B
| $26.2M | ﹤0.01% |
284,779
+1,680
| +0.6% | +$162K |
|
924
Dycom Industries
DY
$12.3B
| $25.9M | ﹤0.01% |
148,879
+53,027
| +55% | +$9.81M |
|
925
Seagate
STX
$209B
| $25.8M | ﹤0.01% |
299,047
-219,384
| -42% | -$22.1M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.